Related Experiment Video
Updated: Mar 18, 2026

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
Published on: May 3, 2016
[NO and cancer: itinerary of a double agent]
Stéphanie Plenchette1, Sabrina Romagny1, Véronique Laurens1
1Université de Bourgogne Franche-Comté, LIIC EA7269, 7, boulevard Jeanne d'Arc, F-21000 Dijon, France - EPHE, PSL Research University, F-75014 Paris, France.
Abstract:
Protein S-nitrosylation is now recognized as a ubiquitous regulatory mechanism. Like any post-translational modifications, S-nitrosylation is critical for the control of numerous cellular processes. It is now clear that S-nitrosylation is playing a double game, enhancing or inhibiting the tumor growth or the induction of cell death. Thanks to research aimed at demonstrating NO cytotoxic effects, new therapeutic strategies based on NO donor drugs have emerged. Although therapeutic NO donors can target a large number of proteins, the cellular mechanism is still not fully understood. This review reflects the current state of knowledge on S-nitrosylated proteins that take part of the oncogenic and apoptotic signaling, putting forward proteins with potential interest in cancer therapy.
Insights
Protein S-nitrosylation, a key regulatory mechanism, influences cell death and tumor growth. Understanding these S-nitrosylated proteins offers potential for novel cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Protein S-nitrosylation is a widespread post-translational modification crucial for cellular processes.
- This modification plays a dual role in cancer, either promoting tumor growth or inducing cell death.
Purpose of the Study:
- To review the current understanding of S-nitrosylated proteins involved in oncogenic and apoptotic signaling pathways.
- To identify proteins with potential therapeutic value in cancer treatment.
Main Methods:
- Literature review of studies on protein S-nitrosylation in cancer.
- Analysis of signaling pathways involving S-nitrosylated proteins in oncogenesis and apoptosis.
Main Results:
- S-nitrosylation significantly impacts tumor progression and cell death.
- Emerging therapeutic strategies utilize nitric oxide (NO) donors, though their precise cellular mechanisms require further elucidation.
- Several S-nitrosylated proteins are implicated in cancer signaling.
Conclusions:
- S-nitrosylation is a critical regulator in cancer biology.
- Further research into S-nitrosylated proteins may lead to the development of targeted cancer therapies.
More Related Videos
Related Concept Videos
Understanding Deception
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Robbers Cave
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Leaving Groups
In general, in a nucleophilic substitution reaction, a nucleophile displaces a functional group, called the leaving group, from the substrate to give a substituted product. A leaving group departs the substrate molecule through heterolytic cleavage, taking the pair of electrons with it to become a relatively stable weak base in the form of an anion or a neutral molecule.
In a...
Routes of Persuasion

